Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: Effect of Silymarin as Add on Therapy on Oxidative Stress, Pulmonary Function and Quality of Life in Stable COPD Patients. [NA]

View source ↗

Summary

A clinical trial update indicates that silymarin is being studied as an add-on therapy in stable COPD to evaluate effects on oxidative stress, pulmonary functio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silymarin (silymarin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | NA | Status: ENROLLING_BY_INVITATION